Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal of Clinical Medicine
|
November 11, 2020
Biotherapies in Uveitis
Mathilde Leclercq, Anne-Claire Desbois, Fanny Domont, et al.
Epilepsia
|
February 15, 2021
Relation between coffee consumption and risk of seizure-related respiratory dysfunction in patients with drug-resistant focal epilepsy
Julie Bourgeois-Vionnet, Julien Jung, Romain Bouet, et al.
Journal of Autoimmunity
|
June 27, 2020
Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis
Mathilde Leclercq, Vincent Langlois, Nicolas Girszyn, et al.
Expert Review of Clinical Immunology
|
July 15, 2021
Perspectives for immunotherapy in noninfectious immune mediated uveitis
Sara Touhami, Julie Gueudry, Mathilde Leclercq, et al.
Journal of Neurology
|
July 23, 2025
Comparing the efficacy and safety of cyclophosphamide, infliximab and methotrexate in neurosarcoidosis: a multicenter retrospective study
Hélène Gomez, Nicolas Noël, Jean Schmidt, et al.
Clinical Rheumatology
|
February 5, 2018
Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review
Mathilde Leclercq, M Le Besnerais, V Langlois, et al.
Journal of Neuroinflammation
|
March 22, 2019
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Laurine Becquet, Catalina Abad, Mathilde Leclercq, et al.
Epilepsia
|
August 18, 2021
Classification of complications of epilepsy surgery and invasive diagnostic procedures: A proposed protocol and feasibility study
Johan Bjellvi, J Helen Cross, Maria Gogou, et al.
Clinical and Experimental Rheumatology
|
March 15, 2024
Potential efficacy of T and B lymphocyte-targeted therapies on articular involvement of patients with rheumatoid arthritis and systemic sclerosis overlap syndrome. Results from a 2-centre series of 19 cases
Nans Lebel, Isabelle Marie, Julien Grosjean, et al.
Hepatitis Monthly
|
October 27, 2015
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
Pierre Pradat, Victor Virlogeux, Marianne Maynard, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal of Clinical Medicine
|
November 11, 2020
Biotherapies in Uveitis
Mathilde Leclercq, Anne-Claire Desbois, Fanny Domont, et al.
Epilepsia
|
February 15, 2021
Relation between coffee consumption and risk of seizure-related respiratory dysfunction in patients with drug-resistant focal epilepsy
Julie Bourgeois-Vionnet, Julien Jung, Romain Bouet, et al.
Journal of Autoimmunity
|
June 27, 2020
Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis
Mathilde Leclercq, Vincent Langlois, Nicolas Girszyn, et al.
Expert Review of Clinical Immunology
|
July 15, 2021
Perspectives for immunotherapy in noninfectious immune mediated uveitis
Sara Touhami, Julie Gueudry, Mathilde Leclercq, et al.
Journal of Neurology
|
July 23, 2025
Comparing the efficacy and safety of cyclophosphamide, infliximab and methotrexate in neurosarcoidosis: a multicenter retrospective study
Hélène Gomez, Nicolas Noël, Jean Schmidt, et al.
Clinical Rheumatology
|
February 5, 2018
Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review
Mathilde Leclercq, M Le Besnerais, V Langlois, et al.
Journal of Neuroinflammation
|
March 22, 2019
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Laurine Becquet, Catalina Abad, Mathilde Leclercq, et al.
Epilepsia
|
August 18, 2021
Classification of complications of epilepsy surgery and invasive diagnostic procedures: A proposed protocol and feasibility study
Johan Bjellvi, J Helen Cross, Maria Gogou, et al.
Clinical and Experimental Rheumatology
|
March 15, 2024
Potential efficacy of T and B lymphocyte-targeted therapies on articular involvement of patients with rheumatoid arthritis and systemic sclerosis overlap syndrome. Results from a 2-centre series of 19 cases
Nans Lebel, Isabelle Marie, Julien Grosjean, et al.
Hepatitis Monthly
|
October 27, 2015
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
Pierre Pradat, Victor Virlogeux, Marianne Maynard, et al.
Page
of 4